AJP - Renal Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol (August 22, 2006). doi:10.1152/ajprenal.00075.2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
292/1/F230    most recent
00075.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lanaspa, M. A.
Right arrow Articles by Sorribas, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lanaspa, M. A.
Right arrow Articles by Sorribas, V.
Submitted on March 1, 2006
Accepted on August 15, 2006

Interaction of MAP17 with NHERF3/4 induces translocation of the renal Na/Pi IIa transporter to the trans-Golgi

Miguel Angel Lanaspa1, Héctor Giral1, Sophia Breusegem2, Nabil Halaihel1, Goretti Baile1, Julia Catalan1, José Alberto Carrodeguas1, Nicholas P Barry2, Moshe Levi2, and Victor Sorribas3*

1 Toxicology, University of Zaragoza, Zaragoza, Zaragoza, Spain
2 Division of Renal Diseases and Hypertension, University of Colorado Health Sciences Center, Denver, Colorado, United States
3 Toxicology, University of Zaragoza, Zaragoza, Spain

* To whom correspondence should be addressed. E-mail: sorribas{at}unizar.es.

The function of the NaPiIIa renal sodium-phosphate transporter is regulated through a complex network of interacting proteins. Several PDZ domain-containing proteins interact with its carboxyl terminus while the small membrane protein MAP17 interacts with its amino end. In order to elucidate the function of MAP17 we identified its interacting proteins using both bacterial and mammalian two-hybrid systems. Several PDZ domain-containing proteins, including the four NHERF proteins, as well as NaPiIIa and NHE3, were found to bind to MAP17. The interactions of MAP17 with the NHERF proteins and with NaPiIIa were further analyzed in opossum kidney (OK) cells. Expression of MAP17 alone had no effect on the NaPiIIa apical membrane distribution, but coexpression of MAP17 and NHERF3 or NHERF4 induced internalization of NaPiIIa, MAP17, and the PDZ protein to the trans-Golgi network (TGN). This effect was not observed when MAP17 was cotransfected with NHERF1/2 proteins. Inhibition of protein kinase C (PKC) prevented expression of the three proteins in the TGN. Activation of PKC in OK cells transfected only with MAP17 induced complete degradation of MAP17 and NaPiIIa. When lysosomal degradation was prevented, both proteins accumulated in the TGN. When the dopamine D1-like receptor was activated both NaPiIIa and MAP17 also accumulated in the TGN. Finally, cotransfection of MAP17 and NHERF3 prevented the adaptive upregulation of phosphate transport activity in OK cells in response to low extracellular phosphate. Therefore, the interaction between MAP17, NHERF3/4 and NaPiIIa in the TGN could be an important intermediate or alternate path in the internalization of NaPiIIa.




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
R. Villa-Bellosta, S. Ravera, V. Sorribas, G. Stange, M. Levi, H. Murer, J. Biber, and I. C. Forster
The Na+-Pi cotransporter PiT-2 (SLC20A2) is expressed in the apical membrane of rat renal proximal tubules and regulated by dietary Pi
Am J Physiol Renal Physiol, April 1, 2009; 296(4): F691 - F699.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. V. Guijarro, J. F.M. Leal, C. Blanco-Aparicio, S. Alonso, J. Fominaya, M. Lleonart, J. Castellvi, S. Ramon y Cajal, and A. Carnero
MAP17 enhances the malignant behavior of tumor cells through ROS increase
Carcinogenesis, October 1, 2007; 28(10): 2096 - 2104.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. V. Guijarro, J. F.M. Leal, J. Fominaya, C. Blanco-Aparicio, S. Alonso, M. Lleonart, J. Castellvi, L. Ruiz, S. Ramon y Cajal, and A. Carnero
MAP17 overexpression is a common characteristic of carcinomas
Carcinogenesis, August 1, 2007; 28(8): 1646 - 1652.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.